{
    "clinical_study": {
        "@rank": "104048", 
        "acronym": "SARCOPENIE", 
        "arm_group": {
            "arm_group_label": "anthropometric measurement", 
            "arm_group_type": "Other", 
            "description": "The muscle area assessed by CT scan imaging at a lumbar vertebral landmark (L3) at the time of diagnosis, at the end of treatment, at 12 and 18 months\nanthropometric measures (weight, height, BMI, brachial and calf circumference) and MNA (mini nutritional assessment)\nalbuminemia, transthyretin, orosomucoid, CRP\nfunctional test to attest the muscular strength: hand grip test, unipodal test, up and go test\nhematological and non-hematological chemotherapy toxicities of cycle 1 and cycle 2\nOS and PFS at 18 and 24 months\nGCB and ABC phenotypes determined by immunohistochemistry and transcriptome analysis"
        }, 
        "brief_summary": {
            "textblock": "This clinical trial is a multicentric prospective study to assess the clinical and\n      prognostic value of sarcopenia in patients older than 70 years with diffuse large B-cell\n      lymphoma."
        }, 
        "brief_title": "Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diffuse Large B Cell Lymphoma", 
            "Grade IIIB Follicular Lymphoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Lymphoma", 
                "Lymphoma, Follicular", 
                "Lymphoma, B-Cell", 
                "Lymphoma, Large B-Cell, Diffuse", 
                "Sarcopenia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Sarcopenia status is assessed by CT scan imaging on the overall survival at 18 months in\n      patients older than 70 years with diffuse large B-cell lymphoma treated by R-CHOP."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients >= 70 years\n\n          -  DLBCL, grade IIIB follicular lymphoma or histologically proven transformed low grade\n             lymphoma\n\n          -  Whatever the IPI score and the performance status\n\n          -  Treated by Rituximab-CHOP or  Rituximab-mini-CHOP\n\n          -  CT scan imaging performed one month or less before inclusion\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  No initial CT scan imaging performed more than one month before inclusion\n\n          -  Positivity for  HCV, HBV and HIV\n\n          -  Anthracycline contra-indication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "98", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01715961", 
            "org_study_id": "CHB 11-02"
        }, 
        "intervention": {
            "arm_group_label": "anthropometric measurement", 
            "description": "To attest the muscular strength: hand grip test, balance test, up and go test", 
            "intervention_name": "anthropometric measurement", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Hand Grip strength test", 
                "Timed get up and go test"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "70 years old", 
            "DLBCL", 
            "Rituximab-CHOP", 
            "Sarcopenia"
        ], 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rouen", 
                    "country": "France", 
                    "zip": "76000"
                }, 
                "name": "Centre Henri Becquerel"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Multicentric Prospective Study to Assess the Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma", 
        "overall_official": {
            "affiliation": "Centre Henri Becquerel", 
            "last_name": "Fabrice JARDIN, MD;PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "progression free survival", 
            "safety_issue": "No", 
            "time_frame": "at 18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01715961"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "progression free survival", 
                "safety_issue": "No", 
                "time_frame": "at 24 months"
            }, 
            {
                "measure": "rate of over grade 2 toxicities", 
                "safety_issue": "No", 
                "time_frame": "at the first and second  courses of chemotherapy (day 21 and day 42)"
            }, 
            {
                "description": "according DASL technology (c-DNA mediated annealing selection extension and ligation)", 
                "measure": "determination of both molecular subtypes GCB and ABC", 
                "safety_issue": "No", 
                "time_frame": "at 24 months"
            }
        ], 
        "source": "Centre Henri Becquerel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Henri Becquerel", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}